Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
10,604,756
Publication Date
3-31-2020
Abstract
The present invention relates to methods for protecting against damage caused by radiation and/or chemotherapy, and methods for treating bone marrow damage by reducing/ inhibiting Latexin expression and/or Latexin activity. The methods comprise administering to a subject in need thereof a pharmaceutical composition comprising an antagonist that reduces expression and/or activity of latexin, wherein latexin is a latexin polynucleotide variant and/or a latexin polypeptide variant that binds to the antagonist.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
14/879,577
Filing Date
10-9-2015
Recommended Citation
Van Zant, Gary; Liang, Ying; and Liu, Yi, "Protection against Ionizing Radiation and Chemotherapy Toxicity via Latexin Regulation" (2020). Internal Medicine Faculty Patents. 11.
https://uknowledge.uky.edu/internalmedicine_patents/11
